Enterprise Financial Services Corp
Position in BMY — Bristol Myers Squibb Co
CIK 1025835
Clayton, MO
Position in BMY
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$442,694
+$18,084 QoQ
Shares Held
7,683
+9.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#1,614
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 77%
Shared 0%
None 23%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Enterprise Financial Services Corp holds $12,653,618 across 10 Drug Manufacturers - General names. BMY ranks #7 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
13,105 | $3,297,741 | |
| 2 | LLY |
ELI LILLY & Co
|
2,069 | $2,481,620 | |
| 3 | MRK |
Merck & Co., Inc.
|
18,619 | $2,392,541 | |
| 4 | JNJ |
Johnson & Johnson
|
8,275 | $2,101,601 | |
| 5 | PFE |
Pfizer Inc
|
24,377 | $586,998 | |
| 6 | AMGN |
Amgen Inc
|
1,281 | $463,875 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
7,683 | $442,694 | |
| 8 | NVS |
Novartis AG
|
2,081 | $326,133 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $442,694 | 7,683 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $424,610 | 7,001 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $373,318 | 6,921 | Shares | Defined | 2026-01-14 | |
| 2025-09-30 | $339,061 | 7,518 | Shares | Defined | 2025-10-15 | |
| 2025-06-30 | $338,564 | 7,314 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $499,264 | 8,186 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $474,877 | 8,396 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $438,548 | 8,476 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $384,193 | 9,251 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $528,958 | 9,754 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $554,608 | 10,809 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $766,069 | 13,199 | Shares | Defined | 2023-10-31 | |
| 2023-06-30 | $895,491 | 14,003 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $952,665 | 13,745 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,009,098 | 14,025 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $992,060 | 13,955 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,101,716 | 14,308 | Shares | Defined | 2022-08-09 | |
| 2022-03-31 | $1,020,082 | 13,968 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $854,880 | 13,711 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,921,486 | 32,474 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $1,019,136 | 15,252 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $990,886 | 15,696 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $985,779 | 15,892 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,024,808 | 16,998 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,038,642 | 17,664 | Shares | Defined | 2020-08-04 | |
| 2020-03-31 | $1,328,505 | 23,834 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||